about
Functional Role of G9a Histone Methyltransferase in CancerEZH2 generates a methyl degron that is recognized by the DCAF1/DDB1/CUL4 E3 ubiquitin ligase complex.Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant.Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170.Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancerEvidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation.Epigenetic regulation in cancer progression.The anticancer effect of chaetocin is enhanced by inhibition of autophagy.Identification of the KAI1 metastasis suppressor gene as a hypoxia target gene.Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells.Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell Immunity.DNAM-1 expression marks an alternative program of NK cell maturation.Long-Range Modulation of PAG1 Expression by 8q21 Allergy Risk Variants.Increased expression of the mannose 6-phosphate/insulin-like growth factor-II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo.Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.G9a in hypoxia: Linking tumor hypoxia and epigenetic regulation.Granulocytes Are Unresponsive to IL-6 Due to an Absence of gp130.D-glucosamine inhibits proliferation of human cancer cells through inhibition of p70S6K
P50
Q26781247-2EEC0AFB-7D32-4B7F-B2B9-F199837504F2Q34305930-1CB5D94A-B0D3-40F8-84F2-F986C315B6DAQ34522502-A4C5C590-7637-4EB3-B5CB-659B55718309Q35940158-5B2D7784-E32B-4F0E-817E-28EE0C565FA3Q36916243-BD239F19-43B6-4FF0-A78E-0FD158BCF39AQ37342144-804D0ADF-47B2-4F99-BBF9-CC6D4A206501Q38463713-B662C79A-ED35-4FF4-985B-7ED43E7E8807Q38793061-459D93D9-6D43-4988-B677-77D40FEFAAEBQ39745302-A4C79979-AB25-4802-A608-83EDBA711777Q40113311-757ADB13-1287-4572-9CD7-A423AAF8DE2BQ40572670-7D471C4E-BA41-4801-8F24-BFEA1D4C36C2Q41146727-990730D2-A616-463B-B50D-FE8DBBCFEB9AQ43247768-4A649726-D265-4887-B63B-9DEE861F34BFQ44603709-F4CAB1F9-49E9-4717-A9D1-A750797DE2B9Q48126035-758B952D-18A9-4018-BB8D-43EC37225DD4Q48277122-D81B0140-84C6-49D8-9C5E-7461930583BBQ52329540-CCA2E6EB-F620-4D85-AED0-4C5983E005E7Q80597008-23A4145D-9A68-4047-BE51-66F009BFB39C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jason S Lee
@ast
Jason S Lee
@en
Jason S Lee
@es
Jason S Lee
@nl
type
label
Jason S Lee
@ast
Jason S Lee
@en
Jason S Lee
@es
Jason S Lee
@nl
prefLabel
Jason S Lee
@ast
Jason S Lee
@en
Jason S Lee
@es
Jason S Lee
@nl
P106
P31
P496
0000-0003-0879-934X